InvestorsHub Logo
Followers 0
Posts 8
Boards Moderated 0
Alias Born 11/30/2023

Re: None

Wednesday, 11/13/2024 8:21:41 AM

Wednesday, November 13, 2024 8:21:41 AM

Post# of 668
Water Tower Research just highlighted the IRB approval for the VELDONA® clinical trial for primary Sjogren's syndrome. This trial, starting in April 2025, could revolutionize treatment for this condition with no approved therapies. https://feeds.issuerdirect.com/news-release.html?newsid=7518957985987465
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AIMD News